Bortezomib (drug)

DRUG3 trials

Sponsors

International Extranodal Lymphoma Study Group (IELSG), Peking University People's Hospital

Conditions

Lymphoma, Mucosa-Associated Lymphoid TissueSystemic AL Amyloidosis

Phase 2

VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy

CompletedNCT00210327

International Extranodal Lymphoma Study Group (IELSG)Lymphoma, Mucosa-Associated Lymphoid Tissue

Start: 2005-07-31End: 2009-04-30Target: 33Updated: 2009-07-22

VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy

TerminatedNCT00210392

International Extranodal Lymphoma Study Group (IELSG)Lymphoma, Mucosa-Associated Lymphoid Tissue

Start: 2005-07-31End: 2007-11-30Updated: 2015-03-30

Unknown Phase

Rapid dFLC Response Predict CHR in AL Amyloidosis

RecruitingNCT06627309

Peking University People's HospitalSystemic AL Amyloidosis

Start: 2024-10-26End: 2026-12-31Target: 50Updated: 2026-03-09